Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 104843847 | 10484384 | 7 | F | 2012 | 20160729 | 20140930 | 20160810 | PER | US-PFIZER INC-2014267227 | PFIZER | 53.00 | YR | M | Y | 98.00000 | KG | 20160810 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 104843847 | 10484384 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | Oral | 50 MG, CYCLIC (ONCE A DAY, 28 DAYS ON WASH OUT PERIOD AND TWO WEEKS OFF WASH OUT PERIOD) | U | X823B | 21938 | 50 | MG | CAPSULE, HARD | |||||
| 104843847 | 10484384 | 2 | SS | SUTENT | SUNITINIB MALATE | 1 | 20 MG, CYCLIC (28 DAY ON 14 OFF) | U | 21938 | 20 | MG | CAPSULE, HARD | |||||||
| 104843847 | 10484384 | 3 | C | VITAMIN C | ASCORBIC ACID | 1 | Oral | 1000 MG, 1X/DAY | 0 | 1000 | MG | TABLET | QD | ||||||
| 104843847 | 10484384 | 4 | C | VITAMIN D | CHOLECALCIFEROL | 1 | UNK | 0 | |||||||||||
| 104843847 | 10484384 | 5 | C | PROPRANOLOL | PROPRANOLOLPROPRANOLOL HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 104843847 | 10484384 | 6 | C | TAMSULOSIN | TAMSULOSIN | 1 | 0.4 MG, UNK | 0 | .4 | MG | |||||||||
| 104843847 | 10484384 | 7 | C | ESZOPICLONE. | ESZOPICLONE | 1 | 3 MG, UNK | 0 | 3 | MG | |||||||||
| 104843847 | 10484384 | 8 | C | VITAMIN D2 | ERGOCALCIFEROL | 1 | Oral | 50000 IU, WEEKLY | 0 | 50000 | IU | CAPSULE | /wk | ||||||
| 104843847 | 10484384 | 9 | C | ASPIR 81 | 2 | Oral | 81 MG, 1X/DAY | 0 | 81 | MG | PROLONGED-RELEASE TABLET | QD | |||||||
| 104843847 | 10484384 | 10 | C | BETA CAROTENE | 2 | Oral | 30 MG, 1X/DAY | 0 | 30 | MG | CAPSULE | QD | |||||||
| 104843847 | 10484384 | 11 | C | CENTRUM Complete | 2 | Oral | UNK UNK, 1X/DAY, (18 MG 400 MCG TABLET) | 0 | TABLET | QD | |||||||||
| 104843847 | 10484384 | 12 | C | LOMOTIL | ATROPINE SULFATEDIPHENOXYLATE HYDROCHLORIDE | 1 | Oral | UNK, (DIPHENOXYLATE HYDROCHLORIDE: 2.5 MG-ATROPINE SULFATE: 0.025 MG) | 0 | TABLET | |||||||||
| 104843847 | 10484384 | 13 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | UNK | 0 | |||||||||||
| 104843847 | 10484384 | 14 | C | VITAMIN B-6 | PYRIDOXINE | 1 | UNK | 0 | |||||||||||
| 104843847 | 10484384 | 15 | C | VITAMIN E | .ALPHA.-TOCOPHEROL | 1 | UNK | 0 | |||||||||||
| 104843847 | 10484384 | 16 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | Oral | 150 MG, 1X/DAY (AT BED TIME HS) | 0 | 150 | MG | TABLET | QD | ||||||
| 104843847 | 10484384 | 17 | C | XANAX | ALPRAZOLAM | 1 | Oral | 1 MG, AS NEEDED (AT BEDTIME (HS) PRN) | 0 | 1 | MG | TABLET | |||||||
| 104843847 | 10484384 | 18 | C | XGEVA | DENOSUMAB | 1 | UNK UNK, CYCLIC (Q4 WK X 3 CYCLES X 1.0) | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 104843847 | 10484384 | 1 | Metastatic renal cell carcinoma |
| 104843847 | 10484384 | 7 | Sleep disorder |
| 104843847 | 10484384 | 17 | Sleep disorder |
| 104843847 | 10484384 | 18 | Renal cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 104843847 | 10484384 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 104843847 | 10484384 | Back pain | |
| 104843847 | 10484384 | Constipation | |
| 104843847 | 10484384 | Contusion | |
| 104843847 | 10484384 | Delusion | |
| 104843847 | 10484384 | Diarrhoea | |
| 104843847 | 10484384 | Dyspnoea | |
| 104843847 | 10484384 | Faeces discoloured | |
| 104843847 | 10484384 | Faeces pale | |
| 104843847 | 10484384 | Fatigue | |
| 104843847 | 10484384 | Gastrooesophageal reflux disease | |
| 104843847 | 10484384 | Gingival bleeding | |
| 104843847 | 10484384 | Hair colour changes | |
| 104843847 | 10484384 | Hypoaesthesia | |
| 104843847 | 10484384 | Impaired healing | |
| 104843847 | 10484384 | Insomnia | |
| 104843847 | 10484384 | Irritability | |
| 104843847 | 10484384 | Muscle spasms | |
| 104843847 | 10484384 | Muscle twitching | |
| 104843847 | 10484384 | Pain in jaw | |
| 104843847 | 10484384 | Paraesthesia | |
| 104843847 | 10484384 | Pruritus | |
| 104843847 | 10484384 | Thinking abnormal | |
| 104843847 | 10484384 | Visual impairment | |
| 104843847 | 10484384 | Yellow skin |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 104843847 | 10484384 | 1 | 201209 | 0 | ||
| 104843847 | 10484384 | 2 | 201209 | 0 | ||
| 104843847 | 10484384 | 3 | 2012 | 0 | ||
| 104843847 | 10484384 | 4 | 2011 | 0 | ||
| 104843847 | 10484384 | 6 | 2011 | 0 | ||
| 104843847 | 10484384 | 7 | 2012 | 0 | ||
| 104843847 | 10484384 | 8 | 2011 | 0 | ||
| 104843847 | 10484384 | 18 | 20130109 | 20130306 | 0 |